Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Orphazyme A/S
  6. News
  7. Most relevant
    ORPHA   DK0060910917

ORPHAZYME A/S

(ORPHA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ORPHAZYME A/S
09/16European ADRs Move Lower in Thursday Trading
MT
09/15European ADRs Modestly Higher Wednesday as Energy Stocks Rally
MT
09/06ORPHAZYME A/S : Final Deadline for Investors with Losses Exceeding $500K to Actively Parti..
BU
09/03THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the Class Acti..
BU
08/31ORPHAZYME A/S : Interim Report First Half 2021 Investor Call.pdf
PU
08/31ORPHAZYME A/S : Interim Report First Half 2021 (Form 6-K)
PU
08/31ORPHAZYME A/S : Interim Report First Half 2021
PU
08/31ORPHAZYME A/S : reports business highlights and financial results in Interim Report First ..
AQ
08/31Orphazyme A/S Maintains its Outlook for the Full Year 2021
CI
08/31Orphazyme A/S Reports Earnings Results for the Half Year Ended June 30, 2021
CI
08/30European ADRs Move Slightly Higher in Monday Trading
MT
08/27European ADRs Rise Nearly 1% Friday Morning
MT
08/25Orphazyme to host Interim Report First Half 2021 investor calláon August 31, 2021
GL
08/24European ADRs Marginally Lower Tuesday as Rio Tinto, Carnival Advance
MT
08/24ORPHAZYME A/S : CytRx Highlights Orphazyme's Published Results From Its Phase 2/3 Trial of..
BU
08/23European ADRs Move Higher in Monday Trading
MT
08/23ORPHAZYME A/S : announces publication of results from its Phase 2/3 trial of arimoclomol i..
AQ
08/23Orphazyme A/S Announces Publication of Results from Its Phase 2/3 Trial of Arimoclomol ..
CI
08/18European ADRs Move Slightly Higher in Wednesday Trading
MT
08/16European ADRs Move Lower in Monday Trading
MT
08/12European ADRs Move Lower in Thursday Trading
MT
08/11European ADRs Move Higher in Wednesday Trading
MT
08/06European ADRs Move Lower in Friday Trading
MT
08/05New publication date for Orphazyme's Interim Report H1 2021
GL
08/05European ADRs Move Higher in Thursday Trading
MT
08/04European ADRs Move Slightly Higher in Wednesday Trading
MT
08/03European ADRs Move Higher in Tuesday Trading
MT
08/02ORPHAZYME A/S : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investors With Lo..
BU
07/22European ADRs Modestly Lower Thursday as Unilever Slides
MT
07/21DEADLINE REMINDER : Law Offices of Howard G. Smith Reminds Investors of Looming Deadline i..
BU
07/20GLANCY PRONGAY & MURRAY LLP : Reminds Investors of Looming Deadline in the Class Action La..
BU
07/19ORPH SHAREHOLDER ALERT : Bronstein, Gewirtz & Grossman, LLC Reminds Orphazyme A/S Sharehol..
BU
07/19CytRx Corporation Announces Closing of $10 Million Offering To Healthcare-Focused Insti..
AQ
07/17EQUITY ALERT : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investors With Los..
BU
07/17THE LAW OFFICES OF FRANK R. CRUZ : Announces the Filing of a Securities Class Action on Be..
BU
07/16GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces the Filing of..
BU
07/16INVESTOR ALERT : Law Offices of Howard G. Smith Announces the Filing of a Securities Class..
BU
07/16SHAREHOLDER ALERT : Robbins LLP Announces that Orphazyme A/S (ORPH) is Being Sued for Misl..
BU
07/16European ADRs Move Lower in Friday Trading
MT
07/15THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Orphazyme A/S (ORPH) on Beha..
BU
07/15GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
07/15European ADRs Move Lower in Thursday Trading
MT
07/15INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Orphazyme A/S (..
BU
07/13SHAREHOLDER ACTION ALERT : The Schall Law Firm Announces the Filing of a Class Action Laws..
BU
07/13EQUITY ALERT : ROSEN, A TOP RANKED LAW FIRM, Encourages Orphazyme A/S Investors with Losse..
BU
07/12ORPHAZYME ALERT : Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Be..
BU
07/12ORPHAZYME INVESTOR ALERT : Investors With Substantial Losses Have Opportunity to Lead the ..
BU
07/12European ADRs Move Higher in Monday Trading
MT
07/07European ADRs Nearly Flat Wednesday as Miners, Techs Gain
MT
07/01European ADRs Move Higher in Thursday Trading
MT
06/30European ADRs Move Lower in Wednesday Trading
MT
06/30CytRx Corporation Announces 24-Month Interim Results of an Open-Label Extension Trial o..
CI
06/29European ADRs Move Lower in Tuesday Trading
MT
06/29ORPHAZYME A/S : To Cut Jobs After US Watchdog Rejects Rare Genetic Disorder Drug
MT
06/28ORPHAZYME A/S : announces restructuring to focus resources on supporting a path forward fo..
PU
06/28European ADRs Down Monday as Ryanair, Carnival, Shell Drop
MT
06/28ORPHAZYME A/S : to Reduce Workforce by Two-Thirds After FDA Action on Arimoclomol, Maintai..
MT
06/28Orphazyme Shrinks Workforce Following FDA Response on Arimoclomol
DJ
06/28Orphazyme presents 36-month data supporting durable response to arimoclomol during Pars..
GL
06/28Orphazyme announces restructuring to focus resources on supporting a path forward for a..
GL
06/28Orphazyme A/S Announces Board Resignation
CI
06/25European ADRs Move Higher in Friday Trading
MT
06/24European ADRs Move Higher in Thursday Trading
MT
06/23European ADRs Edge Higher in Wednesday Trading
MT
06/23Major shareholder announcement
GL
06/22European ADRs Move Lower in Tuesday Trading
MT
06/21European ADRs Move Higher in Monday Trading
MT
06/21CYTRX : Notes Orphazyme's Regulatory Update from the FDA on Arimoclomol for Niemann-Pick D..
AQ
06/21ORPHAZYME A/S : Guggenheim Downgrades Orphazyme to Sell From Neutral
MT
06/21ORPHAZYME A/S : Cowen Downgrades Orphazyme A/S to Market Perform From Outperform
MT
06/18SECTOR UPDATE : Health Care Stocks Finding Modest Support Ahead of Close
MT
06/18SECTOR UPDATE : Health Care Stocks Ailing Friday
MT
06/18Eurostoxx 50 : European shares deepen losses after hawkish Fed comments
RE
06/18Orphazyme, CytRx Shares Slide as FDA Rejects Arimoclomol
DJ
06/18European ADRs Down More Than 2% Friday as Banks, Drillers Drop
MT
1  2  3  4  5Next
Upcoming event on ORPHAZYME A/S
03/04/22